IN2012DN03632A - - Google Patents

Download PDF

Info

Publication number: IN2012DN03632A
Authority: IN; India
Prior art keywords: weight; amount; fos; present; inulin
Prior art date: 2009-11-12

Application number

Other languages

English (en)

Inventor

Zamzam Fariba Roughead

Jalil Benyacoub

Claudia Roessle

Jennifer Rae Mager

Julie Ann Swanson

Norman Alan Greenberg

Douglas Richard Bolster

Rodenas Clara Lucia Garcia

Florence Rochat

Original Assignee

Nestec Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-11-12

Filing date

2010-11-11

Publication date

2015-06-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43567734&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN03632(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-11-11 Application filed by Nestec Sa filed Critical Nestec Sa

2015-06-26 Publication of IN2012DN03632A publication Critical patent/IN2012DN03632A/en

Links

229920001202 Inulin Polymers 0.000 abstract 2
150000004676 glycans Chemical class 0.000 abstract 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
229940029339 inulin Drugs 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
235000016709 nutrition Nutrition 0.000 abstract 2
229920001282 polysaccharide Polymers 0.000 abstract 2
239000005017 polysaccharide Substances 0.000 abstract 2
SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
229920000189 Arabinogalactan Polymers 0.000 abstract 1
239000001904 Arabinogalactan Substances 0.000 abstract 1
229920002907 Guar gum Polymers 0.000 abstract 1
235000019312 arabinogalactan Nutrition 0.000 abstract 1
239000000665 guar gum Substances 0.000 abstract 1
229960002154 guar gum Drugs 0.000 abstract 1
235000010417 guar gum Nutrition 0.000 abstract 1
244000005709 gut microbiome Species 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Pediatric Medicine (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)

IN3632DEN2012 2009-11-12 2010-11-11 IN2012DN03632A (ru)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US26049509P	2009-11-12	2009-11-12
US26443009P	2009-11-25	2009-11-25
US39480510P	2010-10-20	2010-10-20
PCT/US2010/056321 WO2011060123A1 (en)	2009-11-12	2010-11-11	Nutritional composition for promoting gut microbiota balance and health

Publications (1)

Publication Number	Publication Date
IN2012DN03632A true IN2012DN03632A (ru)	2015-06-26

Family

ID=43567734

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN3632DEN2012 IN2012DN03632A (ru)	2009-11-12	2010-11-11

Country Status (14)

Country	Link
US (2)	US9192179B2 (ru)
EP (1)	EP2498626B1 (ru)
JP (2)	JP6006117B2 (ru)
CN (2)	CN102595934A (ru)
AU (1)	AU2010319490B2 (ru)
BR (1)	BR112012011294B1 (ru)
CA (1)	CA2777941C (ru)
DK (1)	DK2498626T3 (ru)
ES (1)	ES2545597T3 (ru)
IN (1)	IN2012DN03632A (ru)
MX (1)	MX336032B (ru)
PH (1)	PH12012500687A1 (ru)
RU (1)	RU2012123959A (ru)
WO (1)	WO2011060123A1 (ru)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102595934A (zh) *	2009-11-12	2012-07-18	雀巢产品技术援助有限公司	用于促进肠微生物群平衡和健康的营养组合物
SG191393A1 (en) *	2010-12-31	2013-08-30	Abbott Lab	Neutral human milk oligosaccharides to promote growth of beneficial bacteria
AU2012273206B2 (en)	2011-06-20	2015-09-24	H.J. Heinz Company Brands Llc	Probiotic compositions and methods
WO2012175639A1 (en) *	2011-06-22	2012-12-27	Universite De Rouen	Arabinogalactan proteins for use as an antiparasitic agent
FI126711B (fi) *	2011-10-12	2017-04-13	Gut Guide Oy	Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
MX2014004722A (es)	2011-10-18	2015-02-05	Nestec Sa	Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea.
TW201318566A (zh) *	2011-11-01	2013-05-16	呂健民	膳食補充劑組合物及其用於調控血糖之方法
WO2013130773A2 (en)	2012-02-29	2013-09-06	Ethicon Endo-Surgery, Inc.	Compositions of microbiota and methods related thereto
ITRM20120084A1 (it)	2012-03-07	2013-09-08	Aboca Spa Societa Agricola	Miscela prebiotica.
WO2014007606A1 (en)	2012-07-05	2014-01-09	N.V. Nutricia	Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
US20150283144A1 (en) *	2012-11-01	2015-10-08	Rijksuniversiteit Groningen	Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
KR102617655B1 (ko)	2012-11-23	2023-12-27	세레스 테라퓨틱스, 인코포레이티드	상승작용적 박테리아 조성물, 그리고 이의 제조 방법 및 용도
US8906668B2 (en)	2012-11-23	2014-12-09	Seres Health, Inc.	Synergistic bacterial compositions and methods of production and use thereof
US20150296851A1 (en) *	2012-11-27	2015-10-22	Shanghai Jiao Tong University	Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
AU2014212003C1 (en) *	2013-02-04	2020-07-16	Seres Therapeutics, Inc.	Compositions and methods for inhibition of pathogenic bacterial growth
WO2014121304A1 (en)	2013-02-04	2014-08-07	Seres Health, Inc.	Compositions and methods
WO2014145958A2 (en)	2013-03-15	2014-09-18	Seres Health, Inc.	Network-based microbial compositions and methods
EP2983662A4 (en) *	2013-03-15	2016-09-21	MicroBiome Therapeutics LLC	FIBER OF ACTIVATED SOYBEAN SLEEVES
GB201312713D0 (en) *	2013-03-22	2013-08-28	Weaver Connie M	Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
GB201305708D0 (en) *	2013-03-28	2013-05-15	Clasado Inc	Novel use
WO2014165975A1 (en) *	2013-04-11	2014-10-16	Bright Drinks Inc.	Compositions for prevention and/or treatment of gastrointestinal imbalances in digestive disorders
ITMI20131467A1 (it) *	2013-09-06	2015-03-07	Sofar Spa	Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MX367109B (es)	2013-11-25	2019-08-05	Seres Therapeutics Inc	Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
US9956282B2 (en)	2013-12-16	2018-05-01	Seres Therapeutics, Inc.	Bacterial compositions and methods of use thereof for treatment of immune system disorders
CA2930348C (en) *	2013-12-20	2023-03-07	Nestec S.A.	Nutritional compositions for reducing intestinal pathogens
MA39710A (fr)	2014-04-23	2015-10-29	Sofar Spa	Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
CN104187624B (zh) *	2014-08-07	2016-06-08	逯明福	综合营养粉及其制备方法
WO2016029113A1 (en) *	2014-08-22	2016-02-25	Abbott Laboratories	Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
MX390246B (es)	2014-09-30	2025-03-20	Kimberly Clark Co	Composicion prebiotica sinergica.
US9539344B2 (en)	2014-09-30	2017-01-10	Kimberly-Clark Worldwide, Inc.	Creped prebiotic tissue
SG11201703395PA (en)	2014-10-31	2017-05-30	Whole Biome Inc	Methods and compositions relating to microbial treatment and diagnosis of disorders
CN104432069A (zh) *	2014-12-22	2015-03-25	威海百合生物技术股份有限公司	一种肠胃通畅片
JP6338113B2 (ja) *	2015-03-31	2018-06-06	株式会社東洋新薬	除脂肪体重の増加剤
CN108369223B (zh) *	2015-12-30	2021-07-06	雀巢产品有限公司	用于测定去脂体重的方法
MX2018007398A (es) *	2015-12-31	2018-08-15	Nestec Sa	Composicion para mejorar la sensacion bucal.
WO2017134240A1 (en) *	2016-02-04	2017-08-10	Universiteit Gent	Use of microbial communities for human and animal health
EP4302824A3 (en)	2016-04-20	2024-03-20	The Board of Trustees of the Leland Stanford Junior University	Compositions and methods for nucleic acid expression and protein secretion in bacteroides
IT201600083376A1 (it)	2016-08-08	2018-02-08	Sofar Spa	Uso di probiotici per aumentare l’assorbimento proteico
ITUA20164188A1 (it)	2016-06-08	2017-12-08	Sofar Spa	Nuovo uso medico di probiotici
US20180030403A1 (en)	2016-07-28	2018-02-01	Bobban Subhadra	Devices, systems and methods for the production of humanized gut commensal microbiota
WO2018057914A1 (en) *	2016-09-22	2018-03-29	The University Of Chicago	Immune response modulation using live biotherapeutics, for conditions such as allergy desensitization
IT201600122724A1 (it)	2016-12-02	2018-06-02	Sofar Spa	Exopolysaccharides and uses thereof
US11566238B2 (en)	2016-12-15	2023-01-31	The Board Of Trustees Of The Leland Stanford Junior University	Compositions and methods for modulating growth of a genetically modified gut bacterial cell
IT201600127498A1 (it)	2016-12-16	2018-06-16	Sofar Spa	Probiotici per uso nella diverticolosi e malattia diverticolare
CN108245530A (zh) *	2016-12-28	2018-07-06	兰州奇正生态健康品有限公司	一种具有润肠通便作用的组合物及其制备方法与用途
ES2683014B1 (es) *	2017-03-23	2019-01-16	Cuetara S L	Galleta infantil sin azúcares añadidos
RU2765232C1 (ru)	2017-06-21	2022-01-26	Эбботт Лабораториз	Способ улучшения роста полезных бактерий в желудочно-кишечном тракте
EP3668527A1 (en)	2017-08-14	2020-06-24	Seres Therapeutics, Inc.	Compositions and methods for treating cholestatic disease
CN111372596A (zh)	2017-08-30	2020-07-03	潘德勒姆治疗公司	用于治疗微生物组相关病症的方法和组合物
GB2566971B (en) *	2017-09-28	2020-12-02	Mjn Us Holdings Llc	Infant formula having decreased protein content
IT201700108039A1 (it) *	2017-09-27	2019-03-27	Neilos S R L	Composizione per il trattamento della costipazione
IT201700108033A1 (it)	2017-09-27	2019-03-27	Neilos S R L	Composizione per il trattamento della costipazione
EP3466276A1 (en)	2017-10-05	2019-04-10	Pharmactive Biotech Products, S.L.	Dietary fiber composition for protecting bioactive compounds during the physiological digestion process
CA3080586A1 (en)	2017-10-30	2019-05-09	Seres Therapeutics, Inc.	Compositions and methods for treating antibiotic resistance
WO2019087280A1 (ja) *	2017-10-31	2019-05-09	森永乳業株式会社	筋肉増量用組成物
US11484547B2 (en) *	2018-01-08	2022-11-01	Performance Labs PTE. LTD.	Compositions and methods for cholesterol, glucose and microbiome control
CN113164526A (zh)	2018-07-19	2021-07-23	潘德勒姆治疗公司	用于微生物植入的方法和组合物
US20200113858A1 (en)	2018-10-15	2020-04-16	Freedom Health, Llc	Human dietary supplement and method for treating digestive system and immune-related disorders
WO2020127630A1 (en) *	2018-12-19	2020-06-25	Cosucra Groupe Warcoing S.A.	Composition comprising chicory root and pea cell wall fiber for treating brachyspira infections
BR112021014094A2 (pt) *	2019-01-18	2021-09-21	Cp Kelco U.S., Inc.	Composição prebiótica e uso da mesma
WO2020161522A1 (en) *	2019-02-06	2020-08-13	Thd S.P.A.	Fiber-based composition
FR3093427B1 (fr) *	2019-03-05	2021-03-05	Mativa Tech	Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
WO2020185857A1 (en) *	2019-03-12	2020-09-17	The Board Of Regents Of The University Of Texas System	Simultaneous blood glucose monitoring and gastric emptying scintigraphy
CN109820865A (zh) *	2019-04-09	2019-05-31	福州大学	低聚木糖和部分水解的瓜尔豆胶复配组合物在预防肥胖及保健品中的应用
JP7321503B2 (ja) *	2019-05-21	2023-08-07	フジ日本精糖株式会社	イヌリンを含む筋肉量減少抑制又は骨密度減少抑制剤
WO2020239996A1 (en)	2019-05-29	2020-12-03	N.V. Nutricia	Non-digestible oligosaccharides for decreased colonic protein fermentation
CN110251530A (zh) *	2019-07-09	2019-09-20	大连大学	一种落叶松阿拉伯半乳聚糖组合物的制备方法及其临床应用
PL3988664T3 (pl) *	2019-08-30	2025-05-12	Hem Pharma Inc.	Sposób badania przesiewowego spersonalizowanych substancji poprawiających środowisko jelitowe z wykorzystaniem procesu pmas
GB201915144D0 (en) *	2019-10-18	2019-12-04	Multigerm Uk Entpr Ltd	Method of promoting SCFA production by gut microbiota
US11751597B2 (en)	2019-11-05	2023-09-12	Alfasigma S.P.A.	Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
CN110679955A (zh) *	2019-11-11	2020-01-14	成都高新区九州华昀医疗美容门诊部有限公司	可改善肠道功能的大鲵活性肽营养组合物
MX2022010647A (es) *	2020-02-27	2022-09-23	Abbott Lab	Metodos para mejorar la salud osea.
US20230218697A1 (en) *	2020-04-24	2023-07-13	Societe Des Produits Nestle S.A.	Composition comprising fibre and mulberry
CN111440841A (zh) *	2020-05-19	2020-07-24	爱礼康生物医药（苏州）有限公司	一种检测膳食纤维对人肠道菌活性影响的方法
JP2023526287A (ja) *	2020-05-20	2023-06-21	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	ビフィドバクテリウム・ロンガムの生存性及び代謝活性に対するイネ科及び／又はマメ科繊維の有益な効果
CA3178133A1 (en) *	2020-05-29	2021-12-02	Julie K SPEARS	Compositions and methods for digestive health in an animal
JP7688866B2 (ja) *	2020-07-14	2025-06-05	物産フードサイエンス株式会社	筋肉量率を増加させる剤および方法、ならびに体脂肪率を減少させる剤および方法
EP4231851A1 (en) *	2020-10-21	2023-08-30	Compagnie Gervais Danone	Acacia gum for iron induced microbial dysbiosis
JP2022072243A (ja) *	2020-10-29	2022-05-17	帝人株式会社	腸内細菌叢改善用組成物及び腸内腐敗物質産生抑制用組成物
CN112715669A (zh) *	2020-11-24	2021-04-30	本溪木兰花乳业有限责任公司	一种改善便秘的牛奶制品及其制备方法
WO2022122958A1 (en)	2020-12-09	2022-06-16	N.V. Nutricia	Fibre mixture for young children
EP4119135A1 (fr) *	2021-07-13	2023-01-18	Luxia Scientific	Methodes pour reequilibrer la flore intestinale chez les patients souffrant de la maladie de parkinson
EP4370104A4 (en) *	2021-07-16	2025-06-04	Purdue Research Foundation	Prebiotic composition and method of use for improving gastrointestinal health in patients with dysbiosis and leaky gut
CN113826892A (zh) *	2021-09-17	2021-12-24	潍坊易北特健康食品有限公司	一种基于肠道微生物调控特定胆汁酸的组合物及制备方法
WO2023054625A1 (ja) *	2021-09-29	2023-04-06	森永乳業株式会社	トレオン酸含有組成物及びその製造方法
JP2023055389A (ja) *	2021-10-06	2023-04-18	株式会社明治	バクテロイデス属細菌の増殖促進剤
CN114224925A (zh) *	2021-12-23	2022-03-25	广东格物生物科技有限公司	一种调节肠道健康的益生菌组合物及其制备方法
ES2955633A1 (es) *	2022-04-26	2023-12-04	Servicio Andaluz De Salud	Composición para la rehabilitación intestinal
CN115025116B (zh) *	2022-07-13	2023-11-21	纽湃腾（北京）医药科技有限公司	一种显著改善胃食管反流伴肠易激综合征的组合物及其应用
WO2025106584A1 (en) *	2023-11-14	2025-05-22	Kate Farms, Inc.	Infant formula
GR1011003B (el) *	2024-02-28	2025-07-22	Cloudpharm Private Company,	Συμπληρωμα διατροφης για την αντιμετωπιση της απωλειας της οστικης πυκνοτητας (οστεοπενια)
WO2025262090A1 (en) *	2024-06-18	2025-12-26	Dsm Ip Assets B.V.	Combination of carotenoids and inulin and uses thereof
CN118681027A (zh) *	2024-07-16	2024-09-24	广州医科大学附属第一医院（广州呼吸中心）	一种丁酸菊粉凝胶及其制备方法
CN121286706A (zh) *	2025-12-01	2026-01-09	仙乐健康科技股份有限公司	用于调整肠道菌群的组合物、营养组合物和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5952314A (en)	1994-04-01	1999-09-14	Demichele; Stephen Joseph	Nutritional product for a person having ulcerative colitis
ES2123903T5 (es)	1995-08-04	2011-02-22	N.V. Nutricia	Composición nutritiva conteniendo fibra.
DK1010374T3 (da)	1998-12-15	2005-11-21	Nestle Sa	Fiberblanding til enterale sammensætninger
MXPA02008447A (es) *	2000-03-01	2002-12-13	Nestle Sa	Formulacion de carbohidrato (adyuvante prebiotico) para el mejoramiento de la respuesta inmune.
EP1175905A1 (en)	2000-07-24	2002-01-30	Societe Des Produits Nestle S.A.	Nutritional Composition
US20020044988A1 (en) *	2000-08-22	2002-04-18	Fuchs Eileen C.	Nutritional composition and method for improving protein deposition
EP1243273A1 (en)	2001-03-22	2002-09-25	Societe Des Produits Nestle S.A.	Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
GB0308104D0 (en)	2003-04-08	2003-05-14	Novartis Nutrition Ag	Organic compounds
ITMI20040956A1 (it)	2004-05-12	2004-08-12	Curti Alessandro	Composizioni alimentari
EP1597978A1 (en) *	2004-05-17	2005-11-23	Nutricia N.V.	Synergism of GOS and polyfructose
US8252769B2 (en) *	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
CA2624921C (en)	2005-10-05	2012-07-10	Nestec S.A.	Nutritional formulation for promoting catch-up growth
ITMI20062031A1 (it) *	2006-10-23	2008-04-24	Velleja Res Srl	Composizioni per la prevenzione del depauperamento della flora intestinale e del danno d'organo successivi a terapia antibiotica
ES2664895T3 (es) *	2006-11-07	2018-04-23	The Procter & Gamble Company	Composiciones que contienen fibra y métodos de fabricación y uso de las mismas
ITMI20071214A1 (it) *	2007-06-15	2008-12-16	S I I T Srl Servizio Internazi	Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
PL2178385T5 (pl)	2007-07-18	2024-10-21	Frieslandcampina Nederland Holding B.V.	Termostabilny napój odżywczy i sposób jego wytwarzania
WO2009075564A1 (en)	2007-12-10	2009-06-18	N.V. Nutricia	Paediatric fibre mixture
JP5992654B2 (ja)	2007-12-21	2016-09-14	ニュートリー株式会社	整腸及び／又は便通改善のための組成物
CN102595934A (zh) *	2009-11-12	2012-07-18	雀巢产品技术援助有限公司	用于促进肠微生物群平衡和健康的营养组合物

2010
- 2010-11-11 CN CN2010800498229A patent/CN102595934A/zh active Pending
- 2010-11-11 PH PH1/2012/500687A patent/PH12012500687A1/en unknown
- 2010-11-11 US US13/502,918 patent/US9192179B2/en active Active
- 2010-11-11 ES ES10779417.4T patent/ES2545597T3/es active Active
- 2010-11-11 DK DK10779417.4T patent/DK2498626T3/en active
- 2010-11-11 EP EP10779417.4A patent/EP2498626B1/en not_active Revoked
- 2010-11-11 JP JP2012538966A patent/JP6006117B2/ja active Active
- 2010-11-11 BR BR112012011294-5A patent/BR112012011294B1/pt active IP Right Grant
- 2010-11-11 AU AU2010319490A patent/AU2010319490B2/en active Active
- 2010-11-11 MX MX2012004778A patent/MX336032B/es unknown
- 2010-11-11 WO PCT/US2010/056321 patent/WO2011060123A1/en not_active Ceased
- 2010-11-11 RU RU2012123959/13A patent/RU2012123959A/ru not_active Application Discontinuation
- 2010-11-11 CN CN201410364998.3A patent/CN104206946A/zh active Pending
- 2010-11-11 IN IN3632DEN2012 patent/IN2012DN03632A/en unknown
- 2010-11-11 CA CA2777941A patent/CA2777941C/en active Active
2015
- 2015-10-20 US US14/887,497 patent/US10015978B2/en active Active
2016
- 2016-02-15 JP JP2016025895A patent/JP6205003B2/ja active Active

Also Published As

Publication number	Publication date
BR112012011294B1 (pt)	2018-03-20
MX2012004778A (es)	2012-06-01
JP6006117B2 (ja)	2016-10-12
AU2010319490A1 (en)	2012-05-03
CN104206946A (zh)	2014-12-17
EP2498626A1 (en)	2012-09-19
JP2013510865A (ja)	2013-03-28
BR112012011294A2 (pt)	2015-09-15
US20160100617A1 (en)	2016-04-14
US20120269865A1 (en)	2012-10-25
JP6205003B2 (ja)	2017-09-27
MX336032B (es)	2016-01-07
RU2012123959A (ru)	2013-12-20
EP2498626B1 (en)	2015-06-17
JP2016166176A (ja)	2016-09-15
PH12012500687A1 (en)	2012-10-29
ES2545597T3 (es)	2015-09-14
AU2010319490B2 (en)	2015-03-19
US9192179B2 (en)	2015-11-24
US10015978B2 (en)	2018-07-10
DK2498626T3 (en)	2015-07-13
WO2011060123A1 (en)	2011-05-19
HK1172516A1 (en)	2013-04-26
CA2777941A1 (en)	2011-05-19
CA2777941C (en)	2018-08-14
CN102595934A (zh)	2012-07-18

Publication	Publication Date	Title
IN2012DN03632A (ru)	2015-06-26
NZ602249A (en)	2014-10-31	Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
MY148405A (en)	2013-04-30	Immunogenic composition
WO2006110406A3 (en)	2007-07-12	Compositions comprising probiotic and sweetener components
MX2010005424A (es)	2010-06-01	Proceso de recubrimiento particulado.
WO2011056487A3 (en)	2011-07-07	Stable thickener formulations
TNSN07360A1 (en)	2008-12-31	Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2015006971A (es)	2015-09-28	Composiciones alimenticias tipo barra.
MY158319A (en)	2016-09-30	Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
MX2019012939A (es)	2019-12-16	Formulaciones que contienen linaclotida para administracion oral.
MX351037B (es)	2017-09-28	Composiciones de goma humectantes de la boca y productos que contienen las mismas.
MX2010004195A (es)	2010-06-02	Trans-clomifeno para el sindrome metabolico.
WO2010133359A3 (en)	2011-01-20	The improvement of gastrointestinal health, immunity and performance by dietary intervention
PL2197456T3 (pl)	2012-07-31	Kompozycje oftalmiczne na bazie polisacharydu z nasion tamaryndowca i kwasu hialuronowego
NZ600094A (en)	2014-10-31	Method of enhancing muscle protein synthesis
NZ605147A (en)	2014-12-24	Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
HRP20171861T1 (hr)	2018-01-26	Dermatološki pripravak koji sadrži heparan sulfat
WO2008073764A3 (en)	2009-07-30	Substantially pure fluorescein
MX342947B (es)	2016-10-18	Tratamiento de diabetes tipo 2.
HRP20231090T1 (hr)	2024-01-05	Pripravci i metode sinergističkog tretmana glikokaliksa
IN2011KN05169A (ru)	2015-07-17
MX2011007288A (es)	2011-09-09	Trozos en composicones alimenticias gelatinosas.
MX2012002165A (es)	2012-04-02	Acidos grasos modificados con silicona, metodo de preparacion y su uso de los mismos.
SG194410A1 (en)	2013-11-29	Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof
UA97359C2 (en)	2012-02-10	Immunogenic composition